Indeed, analyzing BRAF mutations as actionable targets, it was demonstrated that while BRAF-mutated MM cells are sensitive to BRAF inhibition, a paradoxical growth-promoting effect of BRAF inhibitors is present in MM cells with WT BRAF, due to a hyper-activation of the MEK/MAPK pathway (37). This evidence concerns the gene MAP2K7 and Miyoshi myopathy.